Article List

WPRIM Management System> DCMS> Chinese Journal of Laboratory Medicine> 2020> 43> 0

Volume: 43 Issue: 0

1. Biosafety Consensus for 2019 Novel Coronavirus Pneumonia in Clinical Laboratory	Page:E001—E001
2. Understanding the Influence Factors in Viral Nucleic Acid Test of 2019 novel Coronavirus (2019-nCoV)	Page:E002—E002
3. Proposal for detection of 2019-nCoV nucleic acid in clinical laboratories	Page:E003—E003
4. Functional Cell Receptors for Human Coronavirus	Page:E005—E005
5. Analysis of false-negative results for 2019 novel coronavirus nucleic acid test and related countermeasures	Page:E006—E006
6. The laboratory risk assessment and control testing 2019 novel coronavirus in biosafety class II laboratories	Page:E007—E007
7. Advantages and challenges of metagenomic next-generation sequencing (mNGS) in the detection of 2019 novel coronavirus	Page:E008—E008
8. Suggestions casted to the novel coronavirus nucleic acid amplification test from viral pneumonia pathogenesis	Page:E009—E009
9. The management of biosafety risk in clinical laboratory of hospital during the outbreak of 2019 Novel Coronavirus disease	Page:E010—E010
10. Prevention and consideration for the biosafety of laboratory testing under epidemic condition	Page:E011—E011
11. The diagnostic value of joint detection of serum IgMand IgG antibodies to 2019-nCoV in 2019-nCoV infection	Page:E012—E012
12. Expressions of multiple inflammation markers in the patients with 2019 novel coronavirus pneumonia and their clinical values	Page:E013—E013
13. Performance of urea-mediated dissociation in reducing false-positive of 2019-nCoV IgM test	Page:E014—E014
14. Research progress on nucleic acid detection in Novel Coronavirus Pneumonia	Page:E015—E015
15. Analysis of 8 274 cases of new coronavirus nucleic acid detection and co-infection in Wuhan	Page:E016—E016
16. Reasons and solutions for 'false positive results' of 2019 Novel Coronavirus-specific antibodies detection	Page:E020—E020